Adc Therapeutics Is A Biotechnology Company Based In Epalingesswitzerlandfocused On Developing Antibody Drug Conjugatesadcsfor Treating Hematologic Malignancies And Solid Tumorsfounded In June 2011The Company Emerged From Spirogen Ltdand Specializes In Targeted Cancer Therapies That Deliver Cytotoxic Agents Directly To Cancer Cellsaiming To Improve Patient Outcomes The Company S Flagship Productzynlontaa Loncastuximab Tesirine Lpyl Received Fda Approval In April 2021 For Relapsed Or Refractory Diffuse Large B Cell Lymphomaadc Therapeutics Is Also Developing Adct 602A Cd22 Targeting Adc For Acute Lymphoblastic Leukemiaand Utilizes Its Exatecan Platformwhich Incorporates Topoisomerase I Inhibitors To Induce Cancer Cell Deaththe Company Emphasizes Precision Targeting And Innovative Payloads To Meet Unmet Medical Needs In Oncology
